Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monoclonal Antibody in Cervical Cancer Treatment”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Testing effectiveness (Phase 2)Study completedNCT04732494
What this trial is testing

Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
BeiGene 125
Large-scale testing (Phase 3)Study completedNCT02083211
What this trial is testing

Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma

Who this might be right for
Cervical Cancer Recurrent or PersistentPalliative TreatmentMonoclonal Antibody in Cervical Cancer Treatment
National Institute of Cancerología 168
Testing effectiveness (Phase 2)UnknownNCT03713372
What this trial is testing

Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Sinocelltech Ltd. 40
Testing effectiveness (Phase 2)UnknownNCT05898373
What this trial is testing

Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC

Who this might be right for
Salivary Gland Cancer
Peking Union Medical College 120
Testing effectiveness (Phase 2)Looking for participantsNCT04114136
What this trial is testing

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

Who this might be right for
MelanomaNSCLCHepatocellular Carcinoma+5 more
Dan Zandberg 72
Early research (Phase 1)Ended earlyNCT02205398
What this trial is testing

Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy

Who this might be right for
Squamous Cell Carcinoma of Head and Neck (SCCHN)Metastatic Colorectal Cancer
Novartis Pharmaceuticals 13
Testing effectiveness (Phase 2)Looking for participantsNCT05290194
What this trial is testing

Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma

Who this might be right for
RadiotherapyPD-1 InhibitorCapecitabine+1 more
Fifth Affiliated Hospital, Sun Yat-Sen University 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05060432
What this trial is testing

Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors

Who this might be right for
Advanced CancerLung CancerHead and Neck Cancer+1 more
iTeos Belgium SA 153
Testing effectiveness (Phase 2)Active Not RecruitingNCT04718415
What this trial is testing

Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 51
Testing effectiveness (Phase 2)UnknownNCT04508829
What this trial is testing

Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy

Who this might be right for
Oropharyngeal Carcinoma
Fudan University 52
Testing effectiveness (Phase 2)Ended earlyNCT02318901
What this trial is testing

Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer

Who this might be right for
Advanced CancerBreast CancerGastric Cancer+2 more
Western Regional Medical Center 16
Testing effectiveness (Phase 2)Looking for participantsNCT05098119
What this trial is testing

Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)

Who this might be right for
Oral Cavity Squamous Cell CarcinomaOral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 43
Not applicableLooking for participantsNCT02661139
What this trial is testing

Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction

Who this might be right for
Head and Neck CancerOsteonecrosisOsteoradionecrosis
AZ Sint-Jan AV 55
Large-scale testing (Phase 3)UnknownNCT03958890
What this trial is testing

A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Henlius Biotech 489
Testing effectiveness (Phase 2)Study completedNCT01417936
What this trial is testing

Sym004 in SCCHN Patients Failing Anti-EGFR Based Therapy

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Symphogen A/S 26
Testing effectiveness (Phase 2)Looking for participantsNCT06380816
What this trial is testing

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

Who this might be right for
Advanced Solid TumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Non-Small-Cell Lung+8 more
Cancer Research UK 167
Testing effectiveness (Phase 2)UnknownNCT04398524
What this trial is testing

A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

Who this might be right for
Squamous Cell Carcinoma of the Oropharynx
ISA Pharmaceuticals 65
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Large-scale testing (Phase 3)Study completedNCT00006083
What this trial is testing

Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter

Who this might be right for
Cervical CancerChronic Myeloproliferative DisordersLeukemia+6 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT03746431
What this trial is testing

[225Ac]-FPI-1434 Injection

Who this might be right for
Advanced Solid TumoursEndometrial CancerCervical Cancer+7 more
Fusion Pharmaceuticals Inc. 78
Load More Results